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The role of Epithelial to Mesenchymal Transition (EMT) factor Zeb1 is well defined
in metastasis and cancer progression but it’s importance in dendritic cells (DCs) is
unexplored until now. For the first time we report here that Zeb1 controls immunogenic
responses of CD8α+ conventional Type-I (cDC1) DCs. We found that ZEB1 expression
increases significantly after TLR9 stimulation and its depletion impairs activation,
co-stimulation and secretion of important cytokines like IL-6, IL-10 and IL-12 in cDC1
MutuDC line. We further confirmed our findings in primary cDC1 DCs derived from bone
marrow. Co-culture of these Zeb1 knock down (KD) DCs with OT-II CD4+ T helper cells
skewed their differentiation toward Th2 subtype. Moreover, adoptive transfer of activated
Zeb1 KD DCs cleared intestinal worms in helminth infected mice by increasing Th2
responses in vivo. Integrative genomic analysis showed Zeb1 as an activator of immune
response genes in cDC1 MutuDCs as compared to other pathway genes. In addition,
differentially regulated genes in Zeb1 KD RNA-seq showed significant enrichment of Th2
activation pathways supporting our in vitro findings. Mechanistically, we showed that
decreased IL-12 secreted by Zeb1 KD DCs is the plausible mechanism for increased Th2
differentiation. Collectively our data demonstrate that Zeb1 could be targeted in DCs to
modulate T-cell mediated adaptive immune responses.
Keywords: ZEB1, cDC1 dendritic cells, integrative genomics, Th2 response, ChIP-seq, RNA-seq, helminth
infection, immune modulation
INTRODUCTION
Dendritic cells (DCs) are potent antigen presenting cells that play a pivotal role in developing
immune responses as they govern both the initiation and polarization of adaptive immunity
(1–5). The complex classification and nomenclature of DCs has now been refined into two levels,
conventional or classical DCs comprising cDC1 (CD8α+ and CD103+) and cDC2 (CD11b+ and
CD172a+ DCs) depending on their distinct developmental pathways, and the plasmacytoid DCs
(pDCs) (6–8). Genetic and functional studies have revealed that CD8α+ (Lymphoid-resident DCs)
and CD103+ (Non-lymphoid tissue resident migratory DCs) DCs are specialized in antigen cross-
presentation and polarization of Th cells into Th1 subset in response to stimulation via Toll Like
receptor (TLR) ligands such as CpG for TLR9 and poly-IC for TLR3 (6, 7, 9–12). Upon pathogen
encounter, DCs are activated leading to their maturation and migration toward secondary lymph
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nodes where they instruct T helper (Th) cell differentiation
into different subtypes in a signal dependent manner (13–19).
Among the many Th cell subsets, Th1 cells are critical for
host defense against intracellular pathogens, while Th2 cells
defend extracellular parasites (12, 15–17). Priming of Th cells
toward Th1 requires inflammatory cytokine IL-12 whereas Th17
subtype depends on IL-6 and IL-23 cytokines produced by DCs
(20, 21). In contrast, it has been widely accepted that DCs do
not produce the Th2 speciation cytokines like IL-4 and IL-
13. Therefore, decreased secretion of Th1 or Th17 promoting
cytokines by DCs could induce the Th2 cell differentiation
as a default outcome (22–24). Besides, considerable evidences
suggest that DCs are required for optimal Th2 cell priming in
vivo and expression of co-stimulatory molecules like OX40L or
the Notch ligand Jagged-1 by DCs promotes Th2 cell priming
(25, 26). On the other hand, it is explicitly known that cDC1
are prone to induce Th1 responses whereas cDC2 cells provide
cooperative signal for Th2 responses where the IL-4 cytokine
remains the key-determining factor for their polarization (27–
29). Interestingly, there are several reports showing upregulation
of Th2 transcription factor GATA3 through IL-4 by activating
STAT5 and STAT6 transcription factors (TFs), but few of them
indicate that GATA3 expression can be independent of IL-4 as
well (28, 30). Apart from signalingmolecules, it has been reported
that IRF4 depleted DCs are unable to induce Th2 differentiation
(28, 31, 32), whereas increased KLF2 in DCs negatively regulates
Th2 induction (33).
E-Box motif binding TF Zeb1 is a member of Zinc finger TF
family, a known EMT master regulator. TGFβ signaling is one of
the main mechanisms promoting EMT and is known to induce
Zeb1 through SMAD signaling which in turn is well documented
to repress E-cadherin (Cdh1) expression in epithelial cells (34,
35). The mir200 family members are predominantly present in
epithelial cells and fine-tune the transcript expression of Zeb1
through feedback regulation (34, 36). In breast cancer cells, knock
down of Zeb1 inhibits pro-inflammatory cytokines including
IL-6 and IL-8 (37). Similarly, it has been widely reported that
EMT in tumors is positively induced by inflammation (36, 38–
41). In contrast, Zeb1 has been reported to repress IL-2 by
recruiting CTBP2 at its proximal promoter in T-cells irrespective
of activation (42). There are reports suggesting higher expression
of Zeb1 in migratory Langerhans cells, pertinent for their
migration to secondary lymph nodes to present antigens to
Th cells (43). This indicated that Zeb1 might be playing an
important role in cDC1 axis of immune biology beyond just
migratory properties. A forward genetic screen also revealed
Zeb1 requirement for marginal zone of peritoneal B-1 B-cell
development, T-cell development, germinal center formation,
and memory B-cell responses (44). Though Zeb1 has been widely
studied in cancer biology, few evidences with immunity and
inflammation make it a potential candidate to look upon for its
role in cDCs trajectory.
Here in this study, we investigated the role of Zeb1 in
CD8α+ cDC1 DCs and found it to be pertinent for their
activation, co-stimulation and secretion of important immune
response cytokines like IL-10 and IL-12. As a result, Zeb1
depleted DCs generated a strong Th2 phenotype ex vivo and in
vivo, independent of IL-4 cytokine. Integrative genomic analysis
demonstrated that Zeb1 has an indirect control on important
cDC1 response cytokines and it does not act as a global repressor
of immune response genes in DCs.
METHODS
Dendritic Cell (DC) Culture
Here in this study we have used CD8α+ cDC1 MutuDC
line recently developed by Prof. Hans Acha-Orbea’s group.
They have extensively characterized and compared these DC
lines with primary CD8α+ cDC1 DCs and reported that they
perfectly mimic ex vivo immature CD8α+ DCs isolated from
spleen of C57BL/6 mice (9). The DCs were grown in IMDM-
glutamax (GIBCO) buffered with NaHCO3 and supplemented
with 8–10% heat inactivated FCS (tested for endotoxin toxicity
toward DC cultures), 10mM HEPES (GIBCO 15630), 50µM
β-Mercaptoethanol (GIBCO 31350), and 50 U/mL of penicillin
and 50µg/mL streptomycin (GIBCO 15070). The cells were
maintained at 37◦C in a humidified incubator with 5% CO2.
These DCs were dissociated with short incubation in non-
enzymatic, 5mM EDTA-based cell dissociation buffer (5mM
EDTA in 20mMHEPES-PBS) at 37◦C.
For in vitro experiments, the DCs were plated in 6-well
plates at a density of 5 × 105 cells/ml overnight. The cells were
then challenged with different activation media containing TLR9
agonist CpG-B (Invivogen, cat no. tlrl-1826), TLR3 agonist pIC
(Invivogen, cat no. tlrl-pic) and CpG+pIC for 2, 6, and 12 h.
For performing RT-qPCR analysis the cells were washed in the
plate once with PBS followed by addition of RNA-later (LBP) lysis
buffer (Macherey-Nagel) for lysis of cells. The plates were then
stored at −80
◦
C until further RNA isolation and processing of
samples.
Generation of Stable Zeb1 KD CD8α+
MutuDCs
For generating stable Zeb1 knockdown and corresponding
control DCs, lentiviral vector pLKO.1 (Sigma) containing
three different Zeb1-specific shRNAs or control shRNA
were used. Viral particles packaged with shRNA expressing
transfer plasmids were produced in 293T cells using Cal-Phos
(CaPO4) mammalian transfection kit (Clontech) according to an
optimized protocol (45). 293T cells were transfected with transfer
plasmids containing three different Zeb1 shRNAs or control
shRNAs along with packaging plasmids (pCMVR8.74 and
pMD2G). After 12–14 h the culture medium was replenished and
supernatant containing viral particles were collected after 24 h in
50ml conical tubes. Viral particle-containing culture supernatant
was filtered through 0.45µm syringe filters (PES filters) and
preserved at −80◦C in small aliquots. For transduction of
shRNA containing viruses in CD8α+ cDC1 MutuDC lines, the
cells were plated at a density of 1.5 × 105 cells/well of 12 well
plate followed by transduction with virus particles containing
supernatant. The media was replaced with fresh media after 12 h
of virus incubation with DCs followed by addition of 1µg/ml
puromycin selection medium after 72 h of media replacement.
The cells were puromycin selected for 2–3 weeks to get stable
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Zeb1 KD cells. The cells were also transduced with control
shRNA-containing viruses to develop control cells for analysis
comparisons. Efficiency of Zeb1 KD was quantified using Zeb1
gene specific primers by RT-qPCR (Supplementary Table 8).
The shRNA that showed significant and maximum decrease in
Zeb1 gene transcript levels compared to control transduced cells
were used for further detailed study.
RNA Isolation and RT-qPCR
The cells preserved in LBP lysis buffer for RT-qPCR experiments
were first taken out from −80◦C and thawed by placing
the plates/tubes on ice. Total RNA was isolated using
NucleoSpin RNA Plus kit (Machery-Nagel) according to
manufacturer’s protocol. RNA concentration was estimated
by nanodrop (Thermo) and then 1 µg of total RNA was
used to prepare cDNA using High capacity cDNA Reverse
Transcriptase kit (Applied biosystems). Quantiative PCR was
performed using SYBR Green master mix (Roche) and PCR
amplification was monitored in real-time using LightCycler-
480 Instrument (Roche). Primer oligonucleotides for qPCR
were designed using universal probe library assay design
system (Roche) and the primer pairs used are listed in
Supplementary Table 8. Primers were optimized for linear and
single product amplification by performing standard curve
assays.
Flow Cytometry (FACS)
Flow cytometric analyses of in vitro and ex vivo cultured
cells were performed using well established protocol for FACS
staining and analysis. For surface and intracellular (IC) staining
5∗105 and 1.5∗106 cells were seeded respectively and stimulated
with CpG, pIC and CpG + pIC for 12 h. After dissociation
from plates, the cultured cells were washed with FACS buffer
(3% FCS in PBS, 5mM EDTA) followed by re-suspension in
surface staining buffer. After washing, fluorochrome conjugated
antibodies for proteins of interest were added to the cells as a
cocktail (Supplementary Table 8). For intracellular (IC) staining
of cytokines the cells were first fixed with 2% paraformaldehyde
followed by permeabilisation using 1x permeabilisation buffer
(eBiosciences). The fixed cells were then resuspended in
intracellular staining buffer and stained with fluorochrome
tagged antibodies for selected cytokines. For optimal staining the
cells were incubated with antibodies for 30min in dark at 4◦C.
After incubation the cells were washed twice with FACS wash
buffer and then acquired for differential expression analysis using
LSRII fortessa flow cytometer (BD Biosciences). The acquired
data was analyzed using FlowJo-X software (Treestar).
We used single color antibody stained cells as controls
using pooled cells from all untreated and treated conditions for
compensation and gating of positive population. In one of the
biological replicates for immune profiling experiments, we used
Florescence Minus One controls (FMO) to gate cells and for
compensation. We found that single color stained and unstained
negative control cells were giving similar results and therefore
we didn’t include FMOs in all our further experiments. From
live cell population (high GFP positive cells) first we removed
doublet cell population and then similar gates were employed
for both control and Zeb1 KD DCs to observe any percentage
cell population differences in surface markers and intracellular
cytokines. Unstimulated DCs do not secrete cytokines therefore
we used these cells stained with similar cocktail of antibodies
for gating the cytokine positive cell population. In addition, we
also analyzed for Median Florescence Intensity (MFI) shifts for
each population in replicates to observe overall activation/co-
stimulation markers and cytokines in control and Zeb1 depleted
DCs.
Bio-Plex Assay for Cytokine Quantitation
From Cell Culture Supernatants
Bio-Plex assay (multiplex ELISA) was used to estimate the
cytokine levels secreted in the cell culture supernatants of Zeb1
KD and control DCs after 12 h of CpG stimulation. After culture,
the supernatants were stored at −80◦C in small aliquots until
analysis. Cytokine levels were estimated using 23-plex-mouse
cytokine assay kit following the vendor recommended protocol
(Biorad).
Generation of Bone Marrow Derived DCs
(BMDCs) for ex-vivo Studies
Six to eight-week-old female C57BL/6 mice were killed by
cervical dislocation and disinfected using 75% ethanol. The tibias
and femurs were removed under sterile conditions, then soaked
in RPMI-1640 medium supplemented with 10% FBS. Both ends
of the bone were cut off with scissors, and the needle of a 1-
mL syringe was inserted into the bone cavity to rinse the bone
marrow out of the cavity into a sterile culture dish with RPMI-
1640 medium (46). The cell suspension in the dish was collected
and centrifuged at 350 g for 5min, and the supernatant was
discarded. The cell pellet was suspended with 1X RBC lysis buffer
(Tonbo: TNB-4300) to lyse the RBCs and incubated for 5–10min
on ice. Cell clumps were then passed through a 70µm strainer
to obtain single cell suspensions. The lysed cells were washed
once with RPMI-1640, counted and used for differentiation into
DCs.
We followed a well-established protocol for differentiation
of BMDCs with slight modifications (47). The cells, suspended
in RPMI-1640 medium supplemented with 10% FBS, were
distributed into 6-well plates at a density of 1 × 106 cell/ml/well.
Subsequently, 1µl/ml of FLT3L containing sera (derived from
Flt3L expressing mice, gift from Hans Acha-Orbea, UNIL,
Lausanne, Switzerland) was added into the medium. The cells
were cultured at 37◦C in an incubator containing 5% CO2 and
left untouched for 5 days. On day 5, the suspended and loosely
attached cells were collected, washed and counted. The cells
were plated into 24-well plate for lentiviral transduction using
concentrated viruses at a density of 0.4∗106 cells/well for each
Zeb1 shRNA and Control shRNA. After 72 h the cells were
stimulated with CpG for 12 h and then immune-profiling was
done at protein level using flow cytometry for observed markers
that were found to be differentially regulated in CD8α+ cDC1
cells in vitro. The antibodies used for staining were same as used
for in vitro experiments.
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Co-culture of DCs With CD4+ T Cells for
Assessing T-Cell Proliferation and
Differentiation
DC-T cell co-culture experiments were performed as described
before (9). Naïve CD4+ T cells were purified from spleen
of TCR-transgenic OT-II mice using CD4+ T cell isolation
kit (EasySepTM Mouse CD4+T cells isolation Kit, Stem Cell
Technologies). Zeb1 KD and control CD8α+ cDC1 DCs were
seeded at a density of 10,000 cells/well in round bottom 96 well
plates followed by pulsing with OVA peptide (aa 323-339) and
CpG for 2 h. After 2 h, purified OT-II T cells were added at
the density of 100,000 cells/well (1:10 ratio) (48). Then T-cell
proliferation and differentiation into distinct Th subtypes Th1,
Th2, Th17 and Tregs were analyzed by FACS. Proliferation was
measured using an amine based dye (eFluor 670). The rate of
T-cell proliferation was inversely proportional to the Median
Fluorescence Intensity (MFI) measured in FACS after 72 h of
co-culture. For Th cell differentiation profiling after 96 h, the co-
cultured T cells were re-stimulated with PMA (10 ng/mL) and
Ionomycin (500 ng/mL) and followed by Brefeldin-A (10µg/mL)
treatment for 5 h to block the intracellular cytokines from being
secreted. After 5 h, fluorochrome conjugated antibodies specific
to different T cell subtypes were used to profile T cells into Th1
(Tbet and IFNγ), Th2 (GATA3, IL-13), Tregs (CD25, FoxP3) and
Th17 (IL-17) (49). For gating effector T cells we used CD44 as a
marker (see Supplementary Table 8 for details of antibodies).
To confirm the default Th2 program recombinant IL-12
(5 ng/ml) and anti-IL4 (5µg/ml) was used in OT-II co-
culture experiments to confirm any perturbation in Th subtype
differentiation using similar antibodies for various subtypes.
Chromatin Immuno-Precipitation (ChIP) for
Zeb1
The ChIP for Zeb1 was performed according to the methods
optimized previously by Raghav and Meyer’s lab (50, 51). For
ChIP assays, 30∗106 CD8a+ cDC1 MutuDCs were seeded in
15 cm2 plates and prepared for ChIP by 10min cross-linking
with 1% formaldehyde (sigma) at room temperature followed by
quenching using 2.5M glycine (sigma) for 10min. The plates
were placed on ice and the cells were scraped and collected
in 50ml conical tubes. The cells were then washed three times
using cold 1x PBS at 2,000 rpm for 10min at 4◦C and the cell
pellets were stored at−80◦C. At the day of the ChIP experiment,
the cells were thawed on ice followed by lysis using nuclei
extraction buffer (50mM HEPES-NaOH pH 7.5, 140mM NaCl,
1mM EDTA pH 8.0, 10% glycerol, 0.5% NP-40, 0.25% Triton-
X100) supplemented with protease and phosphatase inhibitors
(Roche) for 10min at 4◦C on rocker shaker. The prepared nuclei
were then washed using protein extraction buffer (200 mMNaCl,
1mM EDTA pH 8.0, 0.5mM EGTA pH 8.0, 10mM Tris-Cl pH
8.0) supplemented with a protease and phosphatase inhibitors
(Roche) at room temperature for 10min. Washed nuclei were
resuspended in chromatin extraction buffer (1mMEDTA pH 8.0,
0.5mM EGTA pH 8.0, 10mM Tris-Cl pH 8.0 and 1% TritonX-
100) supplemented with protease and phosphatase inhibitors
(Roche) and incubated for 20min on ice for equilibration.
The chromatin was fragmented using a Bioruptor (Diagenode)
sonicator for 30min using high amplitude and 30s ON & 30s
OFF cycles to obtain 200-500 bp size fragments. A cooling
unit was used to circulate the cold water during sonication to
avoid de-crosslinking because of overheating. After sonication,
chromatin length was checked in agarose gel. The fragmented
chromatin was centrifuged at 10,000 rpm for 5min and then
clear supernatant was collected in 15ml conical tubes. The
DNA concentration of the chromatin was estimated using a
Nano-Drop (Thermo) and the chromatin was diluted with
ChIP dilution buffer (1mM EDTA pH 8.0, 10mM Tris-Cl pH
8.0 and 1% TritonX-100 containing protease and phosphatase
inhibitors) to use 150µg/ml of chromatin for each IP. BSA and
ssDNA (Salmon Sperm DNA) preblocked protein-A sepharose
(80 µl/IP) beads were added to the samples on ice and incubated
for 2 h to remove non-specific-binding chromatin. To the
supernatant, 25 µl of rabbit polyclonal anti-Zeb1 (Santa Cruz H-
102) were added to immunoprecipitate the chromatin complex at
4◦C overnight on rocker shaker. After the overnight incubation,
50 µl blocked beads were added to each sample and incubated
for 2.5 h at 4◦C to pull down the respective antibody-chromatin
complexes. The beads were then washed three times with low salt
wash buffer (20mM Tris-Cl pH 8.0, 150mM NaCl, 2mM EDTA
pH 8.0, 0.1% SDS, 1% TritonX-100) followed by two washes
with high salt wash buffer (20mM Tris-Cl pH 8.0, 500mM
NaCl, 2mM EDTA pH 8.0, 0.1% SDS, 1% TritonX- 100), lithium
chloride wash buffer (10mM Tris-Cl pH 8.0, 0.25M LiCl, 1mM
EDTA pH 8.0, 1% NP-40, 1% sodium deoxycholate) and Tris-
EDTA (TE) buffer (10mM Tris-Cl pH 8.0, 1mM EDTA pH
8.0). After removing the wash buffer completely, protein-bound
chromatin complexes were eluted from beads for 30min using
elution buffer (100mM NaHCO3 and 1% SDS in milli-Q water).
The eluted chromatin was then reverse crosslinked by incubating
the eluted supernatant at 65◦C overnight on a heat block after
adding 8 µl of 5M NaCl. Next day DNA was purified from
the reverse cross-linked chromatin by proteinase-K and RNase
digestion followed by purification using PCR purification kit
(Qiagen). The purified DNA was eluted in 40 µl of elution buffer.
ChIP-/RNA-seq Library Preparation for
Next Generation Sequencing (NGS)
The RNA-seq library preparation was performed for Zeb1 KD
and control cDC1 MutuDCs at 0, 6, and 12 h after CpG
activation. As we did time kinetics we included two independent
biological replicates to identify the Zeb1 depletion mediated
global transcriptome changes. For RNA-seq library preparation
2 µg of total RNA was used to isolate mRNA through magnetic
beads using mRNA isolation kit (PolyAmRNA isolationModule,
NEB) followed by RNA-seq library preparation using mRNA
library preparation kit (NEB) strictly following the vendor
recommended protocol. After library preparation concentration
of libraries were estimated using qubit 2.0 (Invitrogen) and
the recommended fragmentation sizes were confirmed by Bio-
analyzer (Agilent). For ChIP-seq library preparation, 30 µl of
ChIP-DNA was processed for library preparation according to
ChIP-seq library preparation recommended protocol (NEB).
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After library preparation and quality check using Bio-analyzer,
the libraries were send to NGS service provider for Illumina
sequencing using Hiseq-2500 instrument.
Western Blotting
Cells were collected in RIPA buffer (0.5M EDTA, 1M Tris-Cl
pH7.5, 1M NaCl, 200mM PMSF, 10% NP-40, 10% SDS, 5%
sodium deoxycholate, 1M sodium orthovanadate and 1X Roche
protease inhibitor) before and after CpG stimulation at different
time points (0, 1, 2, 6, & 12 h). Cells were lysed completely
by sonicating the samples in Bioruptor (Diagenode) for 10min
using high amplitude and 30s ON & 30s OFF cycles. Protein
concentrations were measured in 96 well plate using BCA protein
assay kit (BioRad).
Adoptive Transfer of DCs in Helminth
(Heligmosomoides polygyrus) Infection
Mice Model
For DC Adoptive transfer experiments we took 6–8 week old
female C57BL/6 mice and infected them with 200 infective L3
larvae/mice in PBS though oral gavage. Prof. Nicola Harris from
EPFL (École Polytechnique Fédérale de Lausanne), Lausanne,
Switzerland, provided the infective L3 larvae. The larvae were
hatched from fecal charcoal cultures at day 7 after collection
(52). After 7 days of infection, mice were treated with 100
µl of anti-CD8b antibody/mice followed by adoptive transfer
of 10∗106 CpG pulsed Zeb1 KD and control CD8α+ cDC1
MutuDCs in sterile PBS intra-peritoneally (IP). Two booster
doses of 5∗106 cells pulsed with CpG were adoptively transferred
consequtively after 48 h. After adoptive transfer of DCs the feces
from infected animals were collected for worm eggs counting
after every 24 h time period till day 31 using a well-optimized
protocol. After observing a significant difference in egg count
between Zeb1 KD DC treated and control animals, four mice
from each group were sacrificed for detailed T cell profiling
from mesenteric lymph nodes and the helminth worm counting
from the intestine of the dissected animals. The intestines were
longitudinally opened and flipped to count the worms and to
take pictures. The T cell differentiation into Th1, Th2, Tregs, and
Th17 subtypes was assessed using FACS as detailed above. This
mouse experiment was performed following the institutional
animal ethics guidelines after taking due approval from the
institutional animal ethics committee at ILS, Bhubaneswar, India.
Mixed Lymphocyte Reaction (MLR)
MLR setup was performed following well-documented protocol
with slight modifications (49). The Zeb1 KD and control DCs
were co-cultured with allogenic T cells from spleen of Balb/C
mice. The Zeb1 KD and control CD8α+ DCs were seeded at
a density of 20,000 cells/well in a round bottom 96 well plates
followed by challenge with CpG for 2 h. After 2 h, splenocytes
containing mostly T cells from 6–8 week old Balb/C mice were
added at the density of 200,000 cells/well (1:10 ratio). After 4
days (96 h) of co-culture, T-cell differentiation was assessed using
same method as for OT-II co-culture.
NGS ANALYSIS
Quality Control & Preprocessing
The quality of RNA-seq and ChIP-seq reads from all sequencing
experiments were determined using FastQC v0.11.5 (https://
www.bioinformatics.babraham.ac.uk/projects/fastqc/) tool.
Reads having Phred Score(Q) <30 and over-represented
sequences i.e. primer sequences, adapter sequences were
removed using Trimmomatic (53) (http://www.usadellab.org/
cms/?page=trimmomatic) from both pairs. For binding events
comparison, PU.1 (0 h) and Irf4 (0 and 2 h) ChIP-seq data of
bone marrow-derived dendritic cell (BMDC) provided with LPS
stimulation were accessed form GSE36104 (54).
RNA-seq Analysis
Filtered reads from transcriptome data were aligned with
Tophat2 (55) usingmm10mouse genome assembly and Gencode
M17 (GRCm38.p6) as reference transcript file. Rest of the
alignment parameters remained same as Tophat2 is optimized for
mammalian sequence alignment by default. Cuﬄinks v2.2.1 was
used to calculate the abundance of transcripts from aligned files
in terms of fragments per kilobase per million of reads (FPKM)
and also generated the assembly file for differential expression
using CuffDiff. All the assembly files from biological replicates
were merged using Cuffmerge command from the same tool.
Genes/transcripts form differential expression analysis having p
< 0.05(significance) and q < 0.05 (false discovery rate) were
classified as significant.
ChIP-seq Analysis
Alignment of ChIP-seq data was aligned with Bowtie2 (56)
using mm10 mouse genome assembly as reference genome
and—no-mixed,—no-discordant options to avoid unpaired read
alignments. Aligned reads were deduplicated using Samtools (57)
and randomly down-sampled to 22 million reads using Picard
tool (https://broadinstitute.github.io/picard/). Peak calling was
done using find Peaks tool form Homer suite (58) using a
threshold of 4-fold change against input control and–factor
option. Transcription factor motifs in −100/+100 region of
the peaks were searched using findMotifsGenome.pl, and peaks
were annotated to nearby gene using annotated Peaks.pl. Motifs
obtained from both “De novo” and “Known Motifs” (having
highest motif score) search having p < 10-20 were considered
significant. Aligned reads from BMDC PU.1 and Irf4 ChIP-seq
were compared with Zeb1 ChIP-seq data using SeqMiner (59) k-
means clustering. To validate the ChIP-seq results we randomly
selected Zeb1 peaks found in ChIP-seq to confirm the enrichment
using two independent ChIP-qPCR experiments.
Pathway Analysis
Ingenuity Pathway Analysis (IPA) software fromQiagenwas used
throughout the analysis process and p-value cutoff of 0.05 was
considered significant. All the raw results of pathway analysis are
attached as Supplementary Files.
Visualization
Gene expression scatter plot, pathway bar plots and other
sequencing data representing bar graphs were generated using
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Ggplot2 (https://cran.r-project.org/web/packages/ggplot2/index.
html) R package. The heatmap was generated using Complex
Heatmap R package with row-wise clustering option (60).
RESULTS
EMT Factor Zeb1 KD Suppresses
Activation, Co-stimulation and Cytokine
Production in CD8α+cDC1 DCs
In this study, we have used a CD8α+ cDC1 MutuDC
line recently developed and well characterized by Fuertes
Maracco and colleagues (9). They showed that this DC
line mimic remarkably the primary lymphoid resident cDC1
responses isolated from spleen. While analyzing an unpublished
RNA-seq data from these cDC1 cells, we found that Zeb1
transcript is constitutively expressed in cDC1 and upon TLR9
stimulation by CpG the expression increased significantly
(Supplementary Figures 1A,B). To characterize the functional
role of Zeb1 in cDC1, we generated a stable Zeb1 KD in cDC1
MutuDC line using lentiviral shRNA transduction followed
by puromycin selection. We used three different shRNAs
targeting different regions of Zeb1 transcript and found that
two of them showed significant depletion of Zeb1 transcript
(Supplementary Table 8). For downstream analyses we moved
ahead with one shRNA sequence i.e., shRNA3, which showed
higher Zeb1 depletion. We obtained 55–80% reduction of Zeb1
transcript in stable KD DCs and a concomitant decreased ZEB1
protein levels before and after 0.5, 2, 6, and 12 h after CpG
activation as evident fromwestern blotting analysis (Figures 1A).
The western blot analysis demonstrated low levels of ZEB1
expression in unstimulated cells and a prominently increased
expression within first few hours of CpG challenge that was
decreased at later time points i.e., 6 and 12 h (Figures 1A,B).
After confirming the Zeb1 KD at transcript and protein level
in stable KD DCs, we analyzed the impact of its depletion on
DC activation and concomitant cytokine expression in CD8α+
cDC1 MutuDCs. We performed detailed immune profiling of
these stable Zeb1 KD DCs before and after 2, 6, and 12 h of
CpG stimulation. It has been well established that Zeb1 directly
represses Cdh1 gene and therefore first we analyzed the transcript
expression of Cdh1 gene and found it to be significantly
increased after Zeb1 depletion in cDC1 DCs confirming the
impact of Zeb1 depletion (Figure 1B). Then we investigated
the impact of Zeb1 KD on DC activation and co-stimulation
along with expression of cytokine genes 12 h after CpG challenge
using qPCR, flow cytometry (FACS) and multiplex ELISA
(Bioplex) to profile the Zeb1 mediated immune-modulations.
We found that Zeb1 KD DCs showed significantly reduced
transcript expression of important DC response cytokines Il-
10 and Il-27, while Il-12 (subunit p40) showed significant
and sustained increase after 12 h of CpG stimulation in Zeb1
KD DCs (Figure 1B). Moreover, the Il-12p35 subunit of IL-12
cytokine showed significantly decreased expression after Zeb1
KD (Figure 1B). We did not observe any significant change in
the mRNA expression of Cd80 and Cd86 activation markers
upon Zeb1 KD before and after CpG activation (Figure 1B).
FACS analysis showed significantly decreased expression of
CD80 and CD86 in Zeb1 KD unstimulated DCs as compared
to control cells, but no significant differences were observed
after CpG stimulation (Figure 1C). The MFI analysis showed a
significant increase in CD86 in CpG condition, whereas percent
positive cells showed an insignificant increasing trend as CpG
activation makes nearly 99–100 percent cells positive for CD86
(Figure 1C). The CD40 expression was unchanged in Zeb1 KD as
compared to control DCs, whereas MHC-I and MHC-II percent
positive cells showed a significant decrease in unstimulated
condition (Figures 1C,D). In addition, the MFI shifts depicted a
significantMHC-II decrease before and after CpG activation with
a decreasing trend for MHCI (Figures 1C,D). Consequently the
intracellular levels of IL-10 and IL-27 cytokines were significantly
decreased in Zeb1 KD DCs after CpG activation (Figures 2A,B).
Moreover, the MFI analysis (bar-plots and histograms) also
showed similar trends (Figures 1C,D, 2A). The cytokine IL-6
showed insignificant but decreasing trend (Figure 2A). Besides,
the IL-12p40 levels were significantly increased in 12 h CpG
activated Zeb1 KD DCs. At early time points (2 and 6 h) of CpG
activation, we did not observe any significant change in the IL-
12p40 expression (data not shown). Furthermore to estimate the
secreted cytokine levels, we performed multiplex ELISA i.e., Bio-
plex analysis, which demonstrated a significant decrease in IL-
6, IL-10, IL-12p70, and IFNγ cytokine levels in CpG activated
Zeb1 KD DCs (Figure 2B and Supplementary Figure 1F). We
observed significantly decreased levels of IL-12p70 in the culture
supernatants of 12 h CpG activated Zeb1 KDDCs in contrast to a
significant increase we found for IL-12p40, an important subunit
of this cytokine (Figure 2B). This may be due to significantly
decreased IL-12p35 subunit, which is an exclusive subunit of
bioactive inflammatory cytokine IL-12. Other important DC
markers like PDL1 and IL-27 also showed a significant decrease
after Zeb1 depletion as compared to control DCs (Figures 1C,
2A). These results showed that Zeb1 depletion suppressed DC
activation and co-stimulation leading to decreased secretion of
important DC response cytokines.
The cDC1 MutuDCs that we employed in our study express
high levels of both TLR3 and TLR9 receptors (9). Therefore, we
also treated Zeb1 KD and control DCs with TLR3 ligand pIC
and CpG + pIC simultaneously to activate both TLR3 and TLR9
receptors together.We found that pIC resulted in weak activation
of DCs as compared to CpG whereas simultaneous CpG + pIC
activation resulted in strong activation as evident from CD80
and CD86 expression and synergistic expression of cytokines
like IL-6, IL-10, and IL-12p40 (Supplementary Figures 1C,D).
We found that Zeb1 depletion resulted in similar decrease in
activation, co-stimulation and cytokine genes as we found after
CpG activation. These results further confirmed that Zeb1 KD
results in suboptimal activation of DCs leading to decreased
expression of pro- and anti-inflammatory cytokines in cDC1
DCs, irrespective of any strong antigenic challenge.
To validate our in vitro findings, we generated primary
cDC1 DCs from the bone marrow precursor cells using fms-
like tyrosine kinase 3 ligand (FLT3L) supplemented medium
(see Methods for details) (47). Bone marrow culture with FLT3L
is the recent method that allow the generation of both cDCs
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FIGURE 1 | Zeb1 transcription factor KD suppresses activation and co-stimulation of CD8α+ cDC1 MutuDCs. (A)Western blot and its densitometric analysis showing
the ZEB1 protein expression kinetics and its KD by shRNA at 0, 0.5, 2, 6, and 12 h after CpG activation in CD8α+ cDC1 DCs n = 2. (B) Bar-plot demonstrating the
fold changes in the transcript expression of DC activation/co-stimulation markers and selected cytokine genes in Zeb1 KD DCs compared to control cells using
(Continued)
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FIGURE 1 | qPCR n = 3. (C) Scatter-plots showing the percentage positive cells for cell-surface expression of activation and co-stimulatory markers CD80, CD86,
MHC-I, MHC-II, CD40, and PDL1 on Zeb1 KD cDC1 MutuDCs compared to control cells before and after 12 h CpG activation. The corresponding panels with bar
plots depict the Median Florescence Intensity (MFI) shifts for the respective genes n = 6–12. (D) Representative histogram plots demonstrating the MFI shift observed
for the activation/co-stimulatory markers and cytokines. p-values are calculated using two tailed unpaired student’s t-test, error bars represent SEM. *≤0.05, **≤0.01,
***≤0.001.
and pDCs. In purview of published reports, which suggests
that FLT3L derived DCs (FL-DCs) are CD11chiCD24hi and
CD11blow, are putative of CD8α+ cDC1 equivalent (47, 61),
therefore we gated CD11c+CD24+MHCII+ population in FACS
to analyze the impact of Zeb1 transient depletion on cDC1
activation and cytokine expression. We found that transient KD
of Zeb1 in primary cDC1 cells using Zeb1 shRNA reduced their
activation, co-stimulation and production of cytokines like IL-
6, IL-10, IL-12p40, and IL-27 as compared to control KD DCs
(Figures 3A–D and Supplementary Figure 2A). In contrast to
Zeb1 KD MutuDCs, IL-12p40 showed decreased expression in
BMDCs. This could be due to transient Zeb1 KD, differential
expression kinetics of IL-12p40 in BMDCs or due to cell
heterogeneity of BMDCs.We also found that Zeb1 is expressed at
similar levels in different primary DC subsets cDC1, cDC2, and
pDCs isolated from spleen of FLT3L transgenic mice. Here we
have focused on the role of Zeb1 in cDC1 DCs but it would be
further intriguing to explore its importance in other DC subsets
as well (Supplementary Figure 2F).
OT-II T Helper Cells Co-cultured With Zeb1
KD DCs Enhanced Th2 Responses
As we found a consistent decrease in all the measured cytokines
in Zeb1 KD DCs we were interested to identify if Zeb1 KD
cDC1 MutuDCs would functionally interfere in T-helper (Th)
cell differentiation. For the same, Zeb1 KD and control DCs were
pulsed with OTII peptide with or without CpG for 2 h. Then,
CD4+ Th cells isolated from spleen of OT-II transgenic mice
were labeled with a proliferation dye efluor 670 followed by co-
culture with these DCs for 72 h. Upon priming by DCs, the naïve
T helper cells first undergo several rounds of clonal amplification
and then polarization into various effector subtypes depending
upon the DC responses (62, 63). We found that Zeb1 KD
DCs induced higher antigen-specific CD4+ Th cell proliferation
compared to control DCs (Figure 4A). This was also observed
when DCs had been previously stimulated with CpG, which
induced even higher T cell proliferation after 3 days of co-
culture (Figures 4A,B). As we observed a decrease in activation
and co-stimulation markers in Zeb1 KD DCs the increased
proliferation of T cells was puzzling and therefore we looked into
expression of IL-2 in cell culture supernatants of Zeb1 KD and
control cells by Bio-plex. We found increased IL-2 cytokine after
CpG activation in Zeb1 KD DC supernatants as compared to
control cells (Supplementary Figure 2E). In addition, we looked
into T cell differentiation profiles of these co-cultured Th cells.
We found significantly increased differentiation of Zeb1 KD
DCs primed Th cells toward Th2 subtype marked by increased
number of GATA3 and GATA3+IL-13+ expressing Th cells
(Figures 4C,D). At the same time the Tbet+IFNγ+ expressing
Th1 cells were majorly decreased in CpG activated Zeb1 KD
condition (Supplementary Figures 2B,C). We did not observe
any significant difference in the Treg differentiation marker
FoxP3 (Supplementary Figure 2D) In unstimulated conditions
we did not found any significant increase in GATA3+ alone
or GATA3+IL-13+ double positive Th cells (Figures 4C,D) and
on the contrary the Tbet+IFNγ+ population was increased
(Supplementary Figures 2B,C)
Moreover we also performed allogeneic mixed lymphocytic
reaction (MLR) assay to confirm the induction of Th2 responses
by Zeb1 KD DCs (Supplementary Figure 3A). We found that
the CD3+CD4+CD44+ effector Th cells showed enhanced
Th2 responses as evidenced by significantly increased GATA3
and IL-4 expression in T cells primed by CpG pulsed Zeb1
KD compared to control DCs (Supplementary Figure 3B). On
the other hand, the Th1 subtype polarization marker Tbet
and its signature cytokine IFNγ showed insignificant but
decreasing trend (Supplementary Figure 3C). These analyses
demonstrated that Zeb1 has the potential to modulate T helper
cell differentiation toward Th2 subtype by modulating DC
responses. We also looked into the impact of Zeb1 KD cDC1
on CD8+ T cell function by gating them separately from
CD4+ Th cells (Supplementary Figure 3D). We found that
the effector CD8+ T cells generated in co-culture with Zeb1
KD DCs produced significantly less Granzyme and Perforin
as compared to CD8+ T cells cultured with control DCs
(Supplementary Figures 3D,E) suggesting Zeb1 as important
factor for inducing optimal T cell cytotoxic responses.
Adoptive Transfer of Zeb1 Depleted DCs
Enhanced Helminth Clearance in Mice
After confirming that Zeb1 KD cDC1 MutuDCs enhanced Th2
cell development in vitro, we were interested in determining
if these DCs were able to affect Th2 responses in an in vivo
parasite infected animal model. Helminth (Heligmosomoides
polygyrus) infection mice model is considered as one of the best-
characterized disease models where it has been established that
perturbation of Th cell subtype responses modulates the worm
load in the intestine (64–67). Besides that the penetrance of
pathogenesis is quite uniform in this disease model. Therefore,
we performed adoptive transfer of CpG pulsed control and
Zeb1 KD MutuDCs in H. polygyrus infected mice to identify
its physiological impact on disease burden. The egg load in the
feces were calculated starting from day 9 (D9) till 1 month after
adoptive transfer of DCs to get an idea about the mature worm
abundance in the intestine of infected animals. At D9, there
were no eggs observed in both Zeb1 KD and control DC treated
animals. This observation is consistent with the previous reports
that worms get mature and move to intestinal lumen on the
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FIGURE 2 | EMT factor Zeb1 KD suppresses expression of important DC response cytokines in cDC1 MutuDCs. (A) Scatter-plots showing the percentage positive
cells for intracellular cytokines IL-10, IL-12p40, IL-6, and IL-27 in Zeb1 KD cDC1 MutuDCs compared to control cells before and after 12 h CpG activation. The
corresponding bar plots and representative histograms in each panel depicting the MFI shifts for these cytokines in Zeb1 KD as compared to control DCs n = 8–12.
(B) Bar-plots demonstrating the Bio-plex based quantitation of IL-10, IL-12p70, and IL-6 cytokines secreted in the supernatants of 12 h CpG activated Zeb1 KD and
control DCs n = 5. p-values are calculated using two tailed unpaired student’s t-test, error bars represent SEM. *≤0.05, **≤0.01, ***≤0.001.
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FIGURE 3 | Zeb1 depletion in bone-marrow derived primary cDC1 DCs showed decreased DC activation, co-stimulation and cytokine secretion n = 6–8. (A) FACS
contour-plot showing the gating strategy used to remove F4/80 positive macrophage population from the CD11c+ DCs to analyze the impact of Zeb1 KD on
CD11c+CD24+MHCII+ DC population. High CD11c+CD24+ double positive DCs were considered as cDC1 DCs for analysis. (B) Scatter-plot and representative
contour plots depicting the percentage of MHCII positive cells in F4/80−CD11c+CD24+ gated BMDCs treated with control and Zeb1 shRNA3 followed by 12 h CpG
stimulation n = 6–8. (C) Scatter-plots and representative contour plots depicting the percentage positive cells for cell surface markers PDL1, CD86, and CD40 in
F4/80−CD11c+CD24+ gated BMDCs treated with control and Zeb1 shRNA3 followed by 12 h CpG stimulation n = 6–8. (D) Scatter-plots showing the percentage
positive cells for intracellular cytokines IL-10, IL-12p40, IL-6, and IL-27 in F4/80−CD11c+CD24+MHCII+ gated BMDCs treated with control and Zeb1 shRNA3
followed by 12 h CpG stimulation n = 6. p-values were calculated using two tailed unpaired student’s t-test, error bars represent SEM. *≤0.05, **≤0.01, ***≤0.001.
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FIGURE 4 | OT-II T helper cells co-cultured with CpG activated Zeb1 KD cDC1 MutuDCs showed enhanced proliferation and differentiation toward Th2 phenotype.
(A) Representative FACS dot-plots showing gated parent population (P1) and proliferating cell population (P2) depicting the changes in proliferation rate of OT-II Th
cells co-cultured for 72 h with Zeb1 KD cDC1 MutuDCs as compared to control DCs with or without CpG pulsing. The corresponding panel shows the histogram
showing the MFI shifts for the proliferation of T cells. n = 3. (B) Bar-plot depicting the percentage of proliferating Th cells (P2) in CD4+ T cells co-cultured with
unstimulated and CpG activated Zeb1 KD and control DCs n = 3. (C) FACS dot-plots showing the percentage positive CD4+CD44+GATA3+ IL-13+ Th cells in Th
cells co-cultured with unstimulated and CpG pulsed Zeb1 KD and control cDC1 MutuDCs for 96 h n = 8. (D) Scatter-plots showing the percentage of double positive
cells for GATA3+ IL-13+ and single positive GATA3+ cells in effector CD4+CD44+ Th cell population n = 8. p-values are calculated using two tailed unpaired
student’s t-test, error bars represent SEM. *≤0.05, ***≤0.001.
D10 and reproduce, resulting in release of eggs in feces (68).
Interestingly at D10, we found that Zeb1 KD DC treated animals
showed less egg counts in their feces compared to control DC
treated animals even after injecting them with equal number
of L3 stage larvae at D0 (Figure 5A). In addition, in Zeb1 KD
DCs treated mice the intestines were almost clear of helminth
infection as no or only few worms were found in the intestine
depicted by the drastically reduced number of eggs on D31
(Figure 5B). Five animals from each group were dissected at D14
and D31 to estimate the worm load in the intestines. We found
that animals treated with CpG activated Zeb1 KD DCs showed
a significant decrease in intestinal helminth load as compared
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to control DC treated animals at D14 (Figure 5C). Besides,
at D31 insignificant differences were observed in intestinal
helminth count in animals treated with unstimulated Zeb1 KD
and control DCs as clear from similar egg counts found at
D31 (data not shown). However, the animals treated with CpG
pulsed Zeb1 KD DCs were almost free of helminth infection in
the intestine as compared to control DC treated mice at D31
(Figure 5D).
Furthermore to identify the impact of CD8α+ cDC1
MutuDCs adoptive transfer on Th cell polarization in animals
leading to the observed phenotype, we performed detailed Th
cell subtype profiling from mesenteric lymph nodes (MLNs)
of all the infected and treated animals at D14 and D31. We
found that in CpG pulsed Zeb1 KD DC treated animals at
D14 presented increased number of Th2 effector CD4+CD44+
cells with significantly higher expression of GATA3 and IL-
5 as compared to control DC treated animals (Figure 5E).
The cytokine IL-13 also showed an insignificant but increasing
trend (Figure 5E). We also observed mice that were treated
with CpG pulsed Zeb1 depleted DCs had reduced Tbet and
IFNγ positive cells in the MLNs. FoxP3, a Treg marker showed
an increase in Zeb1 KD cells, which is well reported to be
elevated during Th2 response (Figure 5E). At D31, we found
a significant increase of IL-5 and IL-10. The cytokine IL-
13 showed increasing trend, whereas IFNγ was significantly
increased (Supplementary Figure 4), which could be the reason
for increased Tregs. Increased Th2 cells in MLNs of helminth
infected animals by treating animals with Zeb1 KD DCs strongly
suggested that Zeb1 depletion in CD8α+ cDC1 could potentiate
Th2 responses in vivo, affecting helminth clearance.
Transcriptome Analysis of Zeb1 KD DCs
Showed an Enrichment of Th2 Pathway
To understand mechanisms underlying the control of Zeb1
mediated DC responses we performed RNA-seq analysis of
control and Zeb1 KD cDC1 MutuDCs at 0, 6, and 12 h after
CpG stimulation. First we confirmed the significantly decreased
transcript levels of Zeb1 and a concomitant significant increase
in Cdh1 expression in RNA-seq datasets at all the analyzed
time points (Supplementary Table 1). Downstream analysis and
manual curation of the genes that were differentially expressed
(corrected p-value ≤ 0.05) in Zeb1 KD DCs showed a significant
down-regulation of cytokines like Il-6, Il-10, and Il-27 along with
several C-type lectin receptors (CLRs) such as Clec1a, Clec4a1,
Cleca7A (Dectin-1), Clec9a and Clec12a as compared to control
cells (Figures 6A,B and Supplementary Table 1). It has been
reported that CLRs present on DCs act in a pathogen/antigen
dependent manner to control Th cell differentiation. Whereas
one of the CLR i.e., DC-SIGN (Cd209c, Cd209f, Cd209g)
showed significant and highest increase in 6 h as well as 12 h
CpG activated Zeb1 KD DCs as compared to control cells
(Figures 6A–C and Supplementary Table 1). We found that
there were more upregulated genes after Zeb1 KD as compared
to down-regulated ones at all the time points suggesting toward
global repressive function of Zeb1 (Figure 6D). There were 229,
308, and 396 genes upregulated after Zeb1 KD at 0, 6 and 12 h
time point, whereas 113, 212, and 234 genes were down regulated
respectively (Figure 6D and Supplementary Table 1). Moreover,
the major anti-inflammatory or tolerogenic cytokine Il-10 was
also significantly decreased at both 6 and 12 h time points in
Zeb1 depleted cells (Figure 6C and Supplementary Table 2).
Ultimately to identify the biological pathways that were
enriched for the genes differentially expressed in Zeb1 KD
DCs after 6 and 12 h CpG activation, we performed Ingenuity
pathway analysis (IPA). We found that at both the time
points there was enrichment of “Dendritic cell maturation,”
“Receptors for bacterial/virus recognition,” “Th2 pathways,”
“Th cell differentiation,” and “STAT3 pathways” (Figure 6E,
Supplementary Figures 5A,B and Supplementary Table 3).
Zeb1 Chip-seq Identified Its Direct and
Indirect Target Genes in CD8α+ cDC1
MutuDCs
We performed ChIP-seq for Zeb1 in unstimulated DCs to
identify the genes that were directly bound and regulated
by Zeb1. The major aim was to correlate the Zeb1 binding
in ChIP-seq with RNA-seq to identify the genes that were
directly controlled by Zeb1 in DCs. We found ∼3400
genomic regions bound by Zeb1 in unstimulated CD8α+ cDC1
(Supplementary Table 4). Upon overlap of genes bound in ChIP-
seq with RNA-seq list we found 76, 130, and 141 genes to
be directly regulated by Zeb1 (Figure 7A). Out of these genes
52, 85, and 95 were upregulated, whereas 24, 45 and 46 genes
were down regulated at 0, 6, and 12 h respectively after Zeb1
KD (Figure 7A). To identify the Zeb1 bound genomic regions
with respect to transcription start site (TSS), we did GREAT
analysis and found that majority of Zeb1 bindings were distal
(775 peaks in ±5KB, 1576 peaks in > ±5KB and < ±50K
region) and far from TSS (Figure 7B). Then, to identify if
Zeb1 DNA binding motif is enriched on these bound peaks we
did de novo motif analysis using HOMER and found 42% of
bound regions showed canonical Zeb1 motif whereas other Zeb1
bound genomic regions showed significant enrichment of DNA
motifs for IRF, ETS (PU.1), E2A and ETS-IRF (PU.1-IRF) TFs
(Figure 7C). To experimentally validate it, we performed ChIP-
seq for PU.1, and the SeqMINER overlap with Zeb1 peaks showed
that indeed PU.1 overlaps strongly at Zeb1 bound genomic
regions (Figure 7D). We also overlapped publicly available
IRF4 ChIP-seq data from unstimulated and 2 h LPS stimulated
BMDCs with Zeb1 and found that IRF4 also showed similar
percentage of overlap as predicted in our de novo motif analysis
(Figures 7C,D and Supplementary Table 5). Moreover, Th1 and
Th2 pathways are enriched for genes annotated to Zeb1-PU1-
IRF4 overlapping genomic regions (Supplementary Figure 5C).
Although Zeb1 is a known transcriptional repressor and there are
more upregulated genes as compared to down regulated genes
in RNA-seq data, we observed that most of the DC immune
response genes were down regulated after Zeb1 depletion in
our in vitro and ex vivo immune-profiling experiments. To
understand it better, we divided all the Zeb1 KD differentially
regulated genes into two groups based on gene ontology, i.e.,
immune response pathway and the other pathway genes and
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FIGURE 5 | Adoptive transfer of CpG activated Zeb1 KD cDC1 MutuDCs in helminth-infected mice enhances worm clearance by increasing Th2 responses. (A)
Line-graphs depicting the Helminth egg counts in the feces of CpG pulsed Zeb1 KD CD8α+ cDC1 MutuDCs and control DC treated mice from D10 to D31. The mice
were infected with H. polygyrus larvae at D0 and treated with CpG pulsed control and Zeb1 KD CD8α+ cDC1 cells consecutively at D7, D9, and D11. The egg
(Continued)
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FIGURE 5 | counting was started from D10 till D31. At day 9 there were no eggs detected in feces of animals n = 10. (B) Representative intestinal sections of
helminth infected mice at D14 and D31 after helminth infection and treatment with CpG pulsed Zeb1 KD and control DC treated animals n = 5. (C) Intestinal worm
load at day 14 in mice adoptively treated with CpG activated Zeb1 KD and control DCs n = 5. (D) Intestinal worm load in mice adoptively treated with CpG activated
Zeb1 KD and control DCs at day 31 after infection n = 5. (E) Scatter-plots for Th1, Th2, and Treg markers like GATA3, IL-5, Tbet, IFNγ, IL-13, and FoxP3 from
detailed immune profiling of CD4+CD44+ effector Th cells isolated form mesenteric lymph nodes of helminth infected animals and treated with activated Zeb1 KD
and control DCs. The corresponding panels also depict bar plots for MFI shifts for each marker in CD4+CD44+ effector Th cell population n = 5. p-values are
calculated using two tailed unpaired student’s t-test, error bars represent SEM. *≤0.05, **≤0.01, ***≤0.001.
looked for any preferential Zeb1 bindings differences in these
two groups. Surprisingly, the ratio of Zeb1 unbound vs. bound
regulated genes was ≥2.5 for both the gene groups. Then,
we analyzed the number of up- vs. down-regulated genes in
immune response and other pathway group and interestingly
we found that similar number of immune response genes
were differentially regulated (ratio of ∼1.0 for up- vs. down
genes) whereas for other pathways gene group there were
more upregulated genes (ratio ≥ 1.6–2.5) (Figures 7E,F and
Supplementary Table 6). This suggested that Zeb1 does not
appear to be a global transcriptional repressor for immune
response genes. Ultimately we analyzed the pathways enriched
for the genes directly bound and regulated by Zeb1 using IPA.
We found “T helper cell differentiation” and “Th2 pathway”
to be significantly enriched for genes differentially regulated at
12 h time point (Figure 7G and Supplementary Table 7). It was
interesting to find that even with such a low number of direct
target genes we found T cell differentiation and Th2 pathway as
highly enriched pathways.
Decreased IL-12 Cytokine Secretion by
Zeb1 KD DCs Leads to Th2 Development
Though we found in our genomic analysis that CLRs were
significantly down regulated along with IL-10, IL-6, and IL-
12p70 cytokines, we were unable to pinpoint specific molecular
mediator leading to the induction of Th2 responses by Zeb1
KD DCs. It has been reported extensively that decreased
secretion of inflammatory IL-12p70 cytokine by DCs results
in default polarization of T cells toward Th2 subtype (22,
28, 31, 69). Therefore we decided to confirm if Zeb1 KD
DCs upon supplementation with recombinant IL-12 (rIL-12)
containing medium decreased the polarization of Th cells
toward Th2 with a concomitant increased Th1 subtype. We
found that OT-II Th cells co-cultured with Zeb1 KD DCs
supplemented with 5 ng/ml rIL-12 resulted into significantly
increased IFNγ expressing Th1 cells comparable to control DCs
(Figure 8A and Supplementary Figure 6A). On the contrary
there was a significantly decreased expression of GATA3+
Th2 cells in Zeb1 KD DCs after rIL-12 supplementation
(Figure 8B and Supplementary Figure 6B). The MFI analysis
of Tbet, Th1 inducing factor also demonstrated significant
increase after rIL-12 addition in Zeb1 KD DCs whereas
GATA3 showed insignificant (p = 0.09) but decreasing trend
(Figures 8C,D). This lead us to conclude that decreased IL-
12p70 secreted by activated Zeb1 KD DCs leads to default
development of Th2 phenotype. As Il-12p35 is an exclusive
subunit of bioactive IL-12 cytokine whereas Il-12p40 subunit
is used as a dimerization partner for other cytokines, we
suspected that the decreased IL-12 in Zeb1 KD DCs may
be due to decreased Il-12p35. Besides, in our RNA-seq data
as well we identified that FPKM of IL12p35 gene was ≥2-
fold decreased in Zeb1 KD DCs as compared to control
cells after 2 h CpG activation (Supplementary Figure 5D).
Furthermore, we found IRF4 transcription factor to be
significantly increased in Zeb1 KD DCs, which is well
reported to repress inflammatory cytokines in DCs to increase
Th2 development (Supplementary Figures 6C,D). Moreover, it
would be difficult to exclude the effect of other molecules such as
CLRs, Stat5b and other cytokines that are differentially regulated
in Zeb1 KD DCs and are reported to impact Th cell polarization
intoTh2 subtypes.
DISCUSSION
Dendritic cells (DCs) are one of the major sentinels of the
immune system that determines the fate of T cell dependent
adaptive responses. Recently it has been proposed that altering
the DC responses can be exploited to affect Th cell subtype
development and hence the diseases phenotypes (70, 71). In
this study, for the first time, we explored the role of EMT
factor Zeb1 in DC function and found that Zeb1 depletion
has immune-modulatory effects which skews the Th cells
toward the Th2 subtype. Besides that, adoptive transfer of Zeb1
KD cDC1 MutuDCs clears helminth infection by inducing
IL-13 and IL-5 secreting Th2 cells in MLNs of infected
animals. Moreover, we identified that Zeb1 KD suppresses
wide-variety of inflammatory response genes including several
CLRs. We concluded that decreased secretion of Th1 inducing
inflammatory cytokine IL-12 by Zeb1 KD cDC1 resulted into
increased Th2 differentiation. Although the impact of other
important factors that were differentially expressed in Zeb1 KD
DCs cannot be ignored (24).
Zeb1 is a well-known EMT master regulator that induces
mesenchymal properties in cancer cells by increasing N-cadherin
and Vimentin levels making it more invasive and metastatic.
It directly controls the expression of E-cadherin (Cdh1) by
binding to its proximal promoter (72–74). We identified that
Zeb1 decrease in our CD8a+ DCs cDC1 correlated with the
levels of Cdh1 and the cells appeared less migratory and
smaller in size in vitro as compared to control DCs (data not
shown). The impact on Cdh1 was so robust that in all our
experiments including RNA-seq we used Cdh1 expression as an
indicative of Zeb1 levels. It has been reported that decreased
activation and co-stimulation of DCs marked by CD80, CD86,
MHC-I and MHC-II resulted into suppression of cytokine
secretion (21–23, 28, 31). Besides, these moderately activated
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FIGURE 6 | Global transcriptome analysis of Zeb1 KD cDC1 MutuDCs showed enrichment of pathways involved in T helper cell differentiation and Th2 pathways.
Two independent biological replicates with three time points (0, 6, 12 h) were used for this analysis. (A) RNA-seq scatter-plot showing the differentially regulated genes
in Zeb1 KD cDC1 MutuDCs as compared to control DCs at 6 h after CpG activation n = 2. (B) Scatter-plot showing the differentially regulated genes in Zeb1
(Continued)
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FIGURE 6 | KD cDC1 MutuDCs as compared to control DCs at 12 h after CpG activation n = 2. (C) Heat-map generated from a list of manually curated genes
identified from differentially regulated gene list in Zeb1 KD RNA-seq data, which includes the genes that are reported to induce Th2 responses upon activation by DCs.
Major DC response genes found to be predominantly regulated after Zeb1 KD are highlighted in bold. To generate this bar-graph Z-score was calculated for each
gene from normalized FPKM values to demonstrate the differential regulation of genes in control and Zeb1 KD DCs at 0, 6, and 12 h after CpG activation. (D) Bar-plot
depicting the number of genes differentially regulated in Zeb1 KD DCs at 0, 6, and 12 h CpG activation as compared to control DCs. Different color codes indicate the
genes that are unique or similar in the list of differentially regulated genes at different time points (0, 6, and 12 h). (E) Bar-plot depicting the biological pathways that
were significantly enriched for the genes that differentially regulated after Zeb1 KD in 6 and 12 h CpG activation as compared to control cells. Ingenuity Pathway
Analysis (IPA) was used to perform pathway enrichment analysis.
DCs are either immune-suppressive leading to development
of anergic T cells or immune-modulatory resulting into Th2
phenotype, which depends on the extent of DC activation (21,
75, 76). We observed a significantly decreased activation of
DCs in Zeb1 KD DCs both before and after CpG activation.
This resulted into decreased cytokine levels in our Zeb1
depleted DCs at both transcript and protein levels. Moreover
we cannot exclude the weak TCR strength in this context
with low CD80, CD86 and MHCII for triggering a Th2
phenotype.
We know that DCs educate naïve Th cells to differentiate into
different subtypes (Th1, Th2, Th17 or Tregs) which depends on
the state of DC activation and the extracellular milieu containing
a cytokine cocktail majorly of IL-4, IL-10, IL-12p70, IL-6, TGFβ
along with others (21, 77). The cDC1 DCs are reported to induce
strong Th1 effector response as compared to their counterpart
cDC2 DCs which have the inherent property of inducing Th2
responses (78). We observed constitutive expression of Zeb1 in
DCs, which could be important to maintain the cDC1-mediated
induction of Th1 cell differentiation. Th1 subtype is generated
if there is higher concentration of inflammatory cytokine IL-
12 in the milieu whereas increased IL-10 or TGFβ with IL-6
leads to Tregs or Th17 phenotype respectively (22, 28). Moreover,
IL-12p40 is also reported to form dimer in the absence of IL-
12p35 subunit, which is a potent inhibitor of IL-12p70 activity
(79). In contrast the cytokine IL-4 is considered pertinent for
Th2 subtype development but it is not secreted by DCs in
general, therefore the mode of Th2 generation is considered as
a default subtype in the absence or decreased secretion of IL-
12 along with absence of other T cell differentiation modulators
(21–23, 28, 30, 31, 77). In addition to cytokine milieu, the cell
surface receptors like CLRs such as CLEC7a, CLEC4a, DC-
SIGN are also reported to skew speciation of Th subtypes in a
pathogen/antigen dependent manner (24, 80, 81). These reports
supported the development of the Th2 phenotype by our Zeb1
KD cDC1 MutuDCs as we observed a significant decrease in
Th1 and Th17 polarizing CLRs along with inflammatory cytokine
IL-12p70 in Zeb1 KD DCs. It has also been reported that
DC-SIGN interacts with ICAM-1 on T cells and enhances the
activation and proliferation of T cells (82). In addition, the
cytokine IL-27 that is reported to suppress Th2 differentiation
was significantly decreased in our Zeb1 KD DCs (83). This
further adds up as a plausible mechanism of Th2 polarization
after Zeb1 depletion.
It has been extensively reported that Th subtype balance i.e.,
Th1 and Th2 controls the helminth H. polygyrus infection in
animals. In Balb/C mice that are Th2 prone, the worms are
cleared from intestine much faster i.e., 8 weeks as compared to
in C57BL/6 animals where the inherent Th1 behavior sustains
the worm infection levels for more than 15–20 weeks (66,
68). Therefore we performed adoptive transfer of activated
Zeb1 KD cDC1 MutuDCs in C57BL/6 mice to identify if at
physiological level Zeb1 KD DCs could skew the Th subtype
toward Th2 and thereby leading to increased worm clearance
from intestine. We found that treatment of the helminth
infected mice with CpG pulsed Zeb1 KD cDC1 MutuDCs
cleared the intestinal worms by D31. Even at D10 the egg
counts were lower in Zeb1 KD DC treated mice, though we
infected all the animals with equal number of larva at D0.
We speculate that it was due to adoptive transfer of CpG
pulsed Zeb1 KD DCs that secrete suboptimal inflammatory
cytokines, at D7 after infection. Furthermore, we also observed
that wild type CD8α+ cDC1 treated animals showed 4- to 5-
fold higher egg counts as compared to PBS treated animals
due to their inherent property of inducing Th1 responses in
vivo. Collectively, this depicted that ZEB1 expression in DCs
is pertinent for initial activation of DCs leading to outburst of
cytokines important for development of optimal inflammatory
Th1 subtypes.
At the mechanistic level it has been demonstrated that Zeb1
acts as a global transcriptional repressor in pre-adipocytes, CD8+
T cells and mesenchymal to epithelial transition (MET) process
(84). In contrast to its role as transcriptional repressor there
are studies indicating Zeb1 as a co-activator, for example, in
complex with Yap1 it activates metastatic inducer genes (85).
In addition, Gene Set Enrichment Analysis (GSEA) of Zeb1
depleted breast cancer cells showed its activating role in the
expression of inflammatory response genes IL-6, IL-8, and IL-
1α (37). Though our transcriptome analysis showed Zeb1 as a
global repressor with higher number of upregulated genes at all
the time points, we observed down-regulation of most of the
immunogenic genes including CLRs, IL-6, IL-10, IL-12, and IL-
27 in Zeb1 KDDCs as compared to control cells. We also showed
here by integrating ChIP-seq and RNA-seq data that Zeb1 does
not act as transcriptional repressor for immune response gene
cluster as for other pathway genes group. It further substantiates
and suggests that Zeb1 forms some differential complex to
control the immune response genes or Zeb1 mostly regulates
them indirectly at transcript level. Even in the cases of EMT and
immune evasion it has been widely reported that EMT process
coincides well with the increased inflammatory environment
(86–88). It might be possible that Zeb1 upregulation during
EMT also results in increased inflammation in the tumor
microenvironment.
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FIGURE 7 | Integrative genomic analysis using ChIP-seq and RNA-seq identified that Zeb1 does not act as global repressor of immune response genes. (A) Bar-plot
depicting the genes that were directly regulated (upregulated and down-regulated) by Zeb1 KD at 0, 6, and 12 h after CpG activation in cDC1 DCs. The direct target
genes of Zeb1 were identified by correlating the gene list from Zeb1 KD RNA-seq and Zeb1 ChIP-seq binding analysis. (B) Genomic Regions Enrichment of
(Continued)
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FIGURE 7 | Zeb1 ChIP-seq bound peaks by annotations tool GREAT showing the genomic locations of Zeb1 bound regulatory regions with respect to gene
transcription start sites (TSS). (C) List of top de-novo motifs significantly enriched at the Zeb1 bound peaks in unstimulated DCs and their annotated TFs. Zeb1 motif
was found to be the top highly enriched motif. (D) SeqMINER clustering demonstrating the overlap of Zeb1 bound peaks in unstimulated CD8α+ cDC1 with PU.1
bound genomic regions in similar condition. The peaks were also overlapped with IRF4 ChIP-seq publicly available data of control and LPS stimulated primary
BMDCs. (E) Heat-map demonstrating the immune response pathway genes that were differentially regulated after Zeb1 KD 0, 6, and 12 h after CpG activation as
compared to control cells. The ChIP-seq binding was also overlapped to identify if Zeb1 directly regulates immune response genes. All the immune response genes
that were differentially regulated (>2-fold up or down-regulated) are listed. The genes that were reported and are important in Th cell polarization through DCs are
highlighted in bold. To generate this bar-graph Z-score was calculated for each gene from normalized FPKM values to demonstrate the differential regulation of genes
in control and Zeb1 KD DCs at 0, 6, and 12 h after CpG activation. (F) Bar-plot depicting the differential regulated genes in Zeb1 KD DCs at 0, 6, and 12 h after CpG
activation. The genes were classification into two different groups based on GO annotation i.e., immune response genes (immune) and other pathway genes (others).
It was observed that in immune response gene group there is preferential upregulation of genes after Zeb1 KD whereas in the other group there was higher number of
upregulated genes (>1.6- to 2.5-fold) compared to down-regulated ones. (G) Bar-plot showing the IPA pathways significantly enriched for the genes that were directly
bound and regulated by Zeb1 at 12 h after CpG activation.
FIGURE 8 | Decreased IL-12 secreted by Zeb1 KD cDC1 DCs is responsible for inducing Th2 differentiation n = 8–10. (A) Scatter-plot depicting an increase in
percentage positive cells for Th1 markers Tbet+ IFNγ+ in Zeb1 KD DCs upon supplementation of recombinant IL-12 and anti-IL4 cytokine in the culture media during
DC -T cell co-culture n = 8–10. (B) Scatter-plot depicting a significant decrease in percentage positive cells for Th2 marker GATA3+ in Zeb1 KD DCs upon addition of
recombinant IL-12 cytokine and anti-IL4 in the culture media during DC-T cell co-culture n = 8–10. (C) Bar-plot representing the MFI for Th1 marker Tbet+ in Zeb1
KD DCs upon supplementation of rIL12 and anti-IL4 cytokine in the culture media during DC -T cell co-culture n = 8–10. (D) Bar-plot representing the MFI for Th2
marker GATA3+ in Zeb1 KD DCs upon supplementation of rIL12 and anti-IL4 cytokine in the culture media during DC -T cell co-culture n = 8–10. p-values are
calculated using two tailed unpaired student’s t-test, error bars represent SEM. *≤0.05, **≤0.01, ***≤0.001).
We would like to conclude with a message that expression
of TF Zeb1 is pertinent for CD8α+ cDC1 activation leading
to immunogenic response generation. It regulates activation
and thereby secretion of cytokines by CD8α+ cDC1 DCs
that are pertinent to induce pathogen/signal specific T cell
responses.
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